Clazakizumab
Appearance
ALD518 a humanized monclonal antibody against interleukin-6.
Clinical trials
Cancer
Phase II trial for advanced cancer.[1]
Rheumatoid arthritis
Phase II trial for rheumatoid arthritis.[2]
This is an old revision of this page, as edited by Rod57 (talk | contribs) at 00:51, 11 November 2009 (start). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
ALD518 a humanized monclonal antibody against interleukin-6.
Phase II trial for advanced cancer.[1]
Phase II trial for rheumatoid arthritis.[2]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |